Bristol-Myers Squibb Company Names Elliott Sigal, M.D., Ph.D., to Board of Directors

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) today announced that Elliott Sigal, M.D., Ph.D., has been elected to its Board of Directors, effective today. Dr. Sigal also will be a member of the Board’s Science and Technology Committee.
MORE ON THIS TOPIC